RHONDA CASTO: Open Payments
NPI 1396148235 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 29 payments from 10 companies in 2025. Trend: 2023 $3,430 · 2024 $1,774 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $178 |
| Neos Therapeutics, LP | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| ABBVIE INC. | 3 | $53 |
| Almatica Pharma LLC | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $15 |
Products named: REXULTI, Adzenys XR-ODT, Auvelity, CAPLYTA, FANAPT, VRAYLAR, LOREEV XR, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
